nodes	percent_of_prediction	percent_of_DWPC	metapath
Tyloxapol—LPL—hypertension	0.783	1	CbGaD
Tyloxapol—LPL—blood vessel—hypertension	0.00889	0.127	CbGeAlD
Tyloxapol—LPL—cardiac ventricle—hypertension	0.0064	0.0913	CbGeAlD
Tyloxapol—LPL—myocardium—hypertension	0.00602	0.0858	CbGeAlD
Tyloxapol—LPL—brainstem—hypertension	0.00486	0.0693	CbGeAlD
Tyloxapol—LPL—nephron tubule—hypertension	0.00441	0.0629	CbGeAlD
Tyloxapol—LPL—adrenal cortex—hypertension	0.00434	0.062	CbGeAlD
Tyloxapol—LPL—heart—hypertension	0.0042	0.0599	CbGeAlD
Tyloxapol—LPL—decidua—hypertension	0.00409	0.0583	CbGeAlD
Tyloxapol—LPL—cardiovascular system—hypertension	0.00396	0.0565	CbGeAlD
Tyloxapol—LPL—kidney—hypertension	0.00388	0.0553	CbGeAlD
Tyloxapol—LPL—cortex of kidney—hypertension	0.00378	0.0539	CbGeAlD
Tyloxapol—LPL—cardiac atrium—hypertension	0.00359	0.0512	CbGeAlD
Tyloxapol—LPL—medulla oblongata—hypertension	0.00339	0.0483	CbGeAlD
Tyloxapol—LPL—adrenal gland—hypertension	0.00314	0.0447	CbGeAlD
Tyloxapol—LPL—endocrine gland—hypertension	0.00272	0.0388	CbGeAlD
Tyloxapol—LPL—central nervous system—hypertension	0.00245	0.0349	CbGeAlD
Tyloxapol—LPL—Disease—GOT2—hypertension	8.4e-05	0.000573	CbGpPWpGaD
Tyloxapol—LPL—Disease—CYBA—hypertension	8.37e-05	0.00057	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MMP2—hypertension	8.3e-05	0.000565	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ALDH2—hypertension	8.28e-05	0.000564	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—OXTR—hypertension	8.22e-05	0.00056	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TRPC3—hypertension	8.14e-05	0.000555	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CX3CR1—hypertension	8.14e-05	0.000555	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—LRP2—hypertension	8.14e-05	0.000555	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CASR—hypertension	8.14e-05	0.000555	CbGpPWpGaD
Tyloxapol—LPL—Disease—CALCA—hypertension	8.09e-05	0.000551	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PPARG—hypertension	8.07e-05	0.00055	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—HBA1—hypertension	8.07e-05	0.00055	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP11A1—hypertension	8.02e-05	0.000546	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HDAC6—hypertension	7.98e-05	0.000544	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—BDKRB1—hypertension	7.98e-05	0.000544	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CX3CL1—hypertension	7.98e-05	0.000544	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—POMC—hypertension	7.96e-05	0.000542	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—FGF2—hypertension	7.88e-05	0.000537	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SLC9A1—hypertension	7.87e-05	0.000536	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTT1—hypertension	7.87e-05	0.000536	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—RHOA—hypertension	7.85e-05	0.000535	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HSPG2—hypertension	7.83e-05	0.000534	CbGpPWpGaD
Tyloxapol—LPL—Disease—ADRBK1—hypertension	7.81e-05	0.000532	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GCLC—hypertension	7.78e-05	0.00053	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CETP—hypertension	7.78e-05	0.00053	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PDE4D—hypertension	7.76e-05	0.000529	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PRKG1—hypertension	7.76e-05	0.000529	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PTH—hypertension	7.76e-05	0.000529	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ADM—hypertension	7.76e-05	0.000529	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GABBR1—hypertension	7.76e-05	0.000529	CbGpPWpGaD
Tyloxapol—LPL—Disease—NOS1—hypertension	7.7e-05	0.000525	CbGpPWpGaD
Tyloxapol—LPL—Disease—CALM2—hypertension	7.67e-05	0.000523	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CYBB—hypertension	7.57e-05	0.000516	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TACR1—hypertension	7.57e-05	0.000516	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GLP1R—hypertension	7.57e-05	0.000516	CbGpPWpGaD
Tyloxapol—LPL—Disease—SLC2A4—hypertension	7.49e-05	0.00051	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP17A1—hypertension	7.45e-05	0.000508	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HRH3—hypertension	7.44e-05	0.000507	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PTGS1—hypertension	7.38e-05	0.000503	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ENO1—hypertension	7.38e-05	0.000503	CbGpPWpGaD
Tyloxapol—LPL—Disease—KL—hypertension	7.35e-05	0.000501	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—RELA—hypertension	7.32e-05	0.000498	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—ALB—hypertension	7.26e-05	0.000494	CbGpPWpGaD
Tyloxapol—LPL—Disease—GOT1—hypertension	7.25e-05	0.000494	CbGpPWpGaD
Tyloxapol—LPL—Disease—PRL—hypertension	7.15e-05	0.000487	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CTGF—hypertension	7.1e-05	0.000484	CbGpPWpGaD
Tyloxapol—LPL—Disease—HDAC1—hypertension	7.04e-05	0.00048	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—HMGCR—hypertension	7.04e-05	0.00048	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GOT2—hypertension	7.04e-05	0.00048	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3R1—hypertension	6.94e-05	0.000473	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NCF2—hypertension	6.92e-05	0.000472	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ADRA2A—hypertension	6.89e-05	0.000469	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NPY—hypertension	6.74e-05	0.00046	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—VWF—hypertension	6.74e-05	0.00046	CbGpPWpGaD
Tyloxapol—LPL—Disease—PRKCE—hypertension	6.69e-05	0.000456	CbGpPWpGaD
Tyloxapol—LPL—Disease—PDGFA—hypertension	6.61e-05	0.00045	CbGpPWpGaD
Tyloxapol—LPL—Disease—TGFBR2—hypertension	6.52e-05	0.000444	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CXCL2—hypertension	6.51e-05	0.000443	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—OXT—hypertension	6.51e-05	0.000443	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HTR1B—hypertension	6.51e-05	0.000443	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AGTR2—hypertension	6.51e-05	0.000443	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—TH—hypertension	6.45e-05	0.000439	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TGFBR1—hypertension	6.43e-05	0.000438	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—F2R—hypertension	6.43e-05	0.000438	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CALM2—hypertension	6.43e-05	0.000438	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PTGS2—hypertension	6.35e-05	0.000433	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SLC2A4—hypertension	6.27e-05	0.000427	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GCG—hypertension	6.27e-05	0.000427	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MMP9—hypertension	6.24e-05	0.000425	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NCF1—hypertension	6.23e-05	0.000425	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EDNRB—hypertension	6.23e-05	0.000425	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TAC1—hypertension	6.17e-05	0.00042	CbGpPWpGaD
Tyloxapol—LPL—Disease—APOB—hypertension	6.16e-05	0.000419	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GOT1—hypertension	6.08e-05	0.000414	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ANXA1—hypertension	6.05e-05	0.000412	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CXCR3—hypertension	6.05e-05	0.000412	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IKBKB—hypertension	5.99e-05	0.000408	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—EP300—hypertension	5.91e-05	0.000403	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP19A1—hypertension	5.9e-05	0.000402	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—STK11—hypertension	5.9e-05	0.000402	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EDNRA—hypertension	5.88e-05	0.000401	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SST—hypertension	5.88e-05	0.000401	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ADRB1—hypertension	5.86e-05	0.000399	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CYBA—hypertension	5.86e-05	0.000399	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FLT1—hypertension	5.86e-05	0.000399	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—DRD3—hypertension	5.86e-05	0.000399	CbGpPWpGaD
Tyloxapol—LPL—Disease—H2AFX—hypertension	5.84e-05	0.000398	CbGpPWpGaD
Tyloxapol—LPL—Disease—PDGFRB—hypertension	5.82e-05	0.000397	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ADRA2A—hypertension	5.76e-05	0.000392	CbGpPWpGaD
Tyloxapol—LPL—Disease—ADCY5—hypertension	5.75e-05	0.000392	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—SRC—hypertension	5.75e-05	0.000392	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GHRL—hypertension	5.73e-05	0.000391	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PLAT—hypertension	5.73e-05	0.000391	CbGpPWpGaD
Tyloxapol—LPL—Disease—PRKCG—hypertension	5.71e-05	0.000389	CbGpPWpGaD
Tyloxapol—LPL—Disease—PRKCA—hypertension	5.68e-05	0.000387	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CALCA—hypertension	5.66e-05	0.000386	CbGpPWpGaD
Tyloxapol—LPL—Disease—YWHAZ—hypertension	5.63e-05	0.000384	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—VEGFA—hypertension	5.6e-05	0.000382	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PTEN—hypertension	5.54e-05	0.000377	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—BDKRB2—hypertension	5.53e-05	0.000377	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—COMT—hypertension	5.48e-05	0.000374	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ADRBK1—hypertension	5.47e-05	0.000373	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CNR1—hypertension	5.43e-05	0.00037	CbGpPWpGaD
Tyloxapol—LPL—Disease—CCR5—hypertension	5.42e-05	0.000369	CbGpPWpGaD
Tyloxapol—LPL—Disease—PRKCD—hypertension	5.42e-05	0.000369	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GNB3—hypertension	5.41e-05	0.000368	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PPARGC1A—hypertension	5.41e-05	0.000368	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—HMOX1—hypertension	5.38e-05	0.000367	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CALM2—hypertension	5.37e-05	0.000366	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CAT—hypertension	5.31e-05	0.000362	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—DRD2—hypertension	5.3e-05	0.000361	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HTR7—hypertension	5.3e-05	0.000361	CbGpPWpGaD
Tyloxapol—LPL—Disease—MTHFR—hypertension	5.29e-05	0.000361	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—EP300—hypertension	5.28e-05	0.00036	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GNAS—hypertension	5.26e-05	0.000359	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PTPN1—hypertension	5.25e-05	0.000357	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GCG—hypertension	5.25e-05	0.000357	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—APOB—hypertension	5.15e-05	0.000351	CbGpPWpGaD
Tyloxapol—LPL—Disease—PDGFB—hypertension	5.15e-05	0.000351	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—KL—hypertension	5.14e-05	0.000351	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NOTCH2—hypertension	5.14e-05	0.000351	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—TGFB1—hypertension	5.14e-05	0.00035	CbGpPWpGaD
Tyloxapol—LPL—Disease—FGFR1—hypertension	5.12e-05	0.000349	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ITGAV—hypertension	5.05e-05	0.000344	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NGFR—hypertension	5.05e-05	0.000344	CbGpPWpGaD
Tyloxapol—LPL—Disease—HIF1A—hypertension	5.05e-05	0.000344	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—EGFR—hypertension	5.04e-05	0.000343	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—KNG1—hypertension	5.03e-05	0.000343	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTM1—hypertension	5.01e-05	0.000342	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AGTR1—hypertension	5e-05	0.000341	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PRL—hypertension	5e-05	0.000341	CbGpPWpGaD
Tyloxapol—LPL—Disease—CALM1—hypertension	4.94e-05	0.000337	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HDAC1—hypertension	4.93e-05	0.000336	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—STK11—hypertension	4.93e-05	0.000336	CbGpPWpGaD
Tyloxapol—LPL—Disease—APOE—hypertension	4.93e-05	0.000336	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CXCL10—hypertension	4.89e-05	0.000333	CbGpPWpGaD
Tyloxapol—LPL—Disease—CAV1—hypertension	4.88e-05	0.000333	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PLG—hypertension	4.88e-05	0.000332	CbGpPWpGaD
Tyloxapol—LPL—Disease—APOA1—hypertension	4.87e-05	0.000332	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ADCY5—hypertension	4.82e-05	0.000328	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GPX1—hypertension	4.8e-05	0.000327	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—TNF—hypertension	4.8e-05	0.000327	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PRKCA—hypertension	4.75e-05	0.000324	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP1A1—hypertension	4.75e-05	0.000324	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ADRB2—hypertension	4.75e-05	0.000323	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PRKCE—hypertension	4.69e-05	0.000319	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CD36—hypertension	4.68e-05	0.000319	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PDGFA—hypertension	4.63e-05	0.000315	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—VAV3—hypertension	4.63e-05	0.000315	CbGpPWpGaD
Tyloxapol—LPL—Disease—NOS2—hypertension	4.59e-05	0.000313	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TGFBR2—hypertension	4.56e-05	0.000311	CbGpPWpGaD
Tyloxapol—LPL—Disease—NOTCH1—hypertension	4.55e-05	0.00031	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GNB3—hypertension	4.52e-05	0.000308	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AVP—hypertension	4.46e-05	0.000304	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—MTHFR—hypertension	4.43e-05	0.000302	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GNAS—hypertension	4.4e-05	0.0003	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PPARA—hypertension	4.35e-05	0.000296	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—APOB—hypertension	4.31e-05	0.000294	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PTK2—hypertension	4.29e-05	0.000293	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EDN1—hypertension	4.24e-05	0.000289	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—AGT—hypertension	4.21e-05	0.000287	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCL5—hypertension	4.21e-05	0.000287	CbGpPWpGaD
Tyloxapol—LPL—Disease—INS—hypertension	4.21e-05	0.000287	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CALM1—hypertension	4.14e-05	0.000282	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—APOE—hypertension	4.13e-05	0.000281	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CAV1—hypertension	4.09e-05	0.000279	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—H2AFX—hypertension	4.09e-05	0.000278	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—RPS6KB1—hypertension	4.08e-05	0.000278	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PDGFRB—hypertension	4.08e-05	0.000278	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—APOA1—hypertension	4.08e-05	0.000278	CbGpPWpGaD
Tyloxapol—LPL—Disease—AKT2—hypertension	4.07e-05	0.000277	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ADCY5—hypertension	4.03e-05	0.000275	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PRKCG—hypertension	4e-05	0.000273	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PRKCA—hypertension	3.97e-05	0.000271	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ITGB3—hypertension	3.97e-05	0.000271	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—YWHAZ—hypertension	3.94e-05	0.000269	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SPP1—hypertension	3.9e-05	0.000266	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NGF—hypertension	3.9e-05	0.000266	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—IL6—hypertension	3.87e-05	0.000264	CbGpPWpGaD
Tyloxapol—LPL—Disease—SERPINE1—hypertension	3.87e-05	0.000263	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PRKCD—hypertension	3.79e-05	0.000258	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCR5—hypertension	3.79e-05	0.000258	CbGpPWpGaD
Tyloxapol—LPL—Disease—FGF2—hypertension	3.74e-05	0.000255	CbGpPWpGaD
Tyloxapol—LPL—Disease—RHOA—hypertension	3.73e-05	0.000254	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HTR2A—hypertension	3.71e-05	0.000253	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—C3—hypertension	3.71e-05	0.000253	CbGpPWpGaD
Tyloxapol—LPL—Disease—PIK3R1—hypertension	3.69e-05	0.000252	CbGpPWpGaD
Tyloxapol—LPL—Disease—NOS3—hypertension	3.69e-05	0.000252	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PDGFB—hypertension	3.61e-05	0.000246	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PPARG—hypertension	3.59e-05	0.000245	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FGFR1—hypertension	3.59e-05	0.000245	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—AKT1—hypertension	3.57e-05	0.000243	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—POMC—hypertension	3.54e-05	0.000242	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HIF1A—hypertension	3.53e-05	0.000241	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—INS—hypertension	3.52e-05	0.00024	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AGT—hypertension	3.52e-05	0.00024	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CALM1—hypertension	3.46e-05	0.000236	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—LEP—hypertension	3.45e-05	0.000235	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—APOE—hypertension	3.45e-05	0.000235	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CAV1—hypertension	3.42e-05	0.000233	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—APOA1—hypertension	3.41e-05	0.000232	CbGpPWpGaD
Tyloxapol—LPL—Disease—MTOR—hypertension	3.41e-05	0.000232	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—KDR—hypertension	3.38e-05	0.00023	CbGpPWpGaD
Tyloxapol—LPL—Disease—PTGS2—hypertension	3.38e-05	0.00023	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—F2—hypertension	3.25e-05	0.000222	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FN1—hypertension	3.25e-05	0.000222	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PRKCB—hypertension	3.25e-05	0.000222	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ALB—hypertension	3.23e-05	0.00022	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NOTCH1—hypertension	3.18e-05	0.000217	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3R1—hypertension	3.09e-05	0.000211	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NOS3—hypertension	3.09e-05	0.000211	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—POMC—hypertension	2.96e-05	0.000202	CbGpPWpGaD
Tyloxapol—LPL—Disease—CDKN1A—hypertension	2.95e-05	0.000201	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—INS—hypertension	2.95e-05	0.000201	CbGpPWpGaD
Tyloxapol—LPL—Disease—PTEN—hypertension	2.94e-05	0.000201	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCL2—hypertension	2.9e-05	0.000198	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IGF1—hypertension	2.85e-05	0.000194	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AKT2—hypertension	2.85e-05	0.000194	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PTGS2—hypertension	2.83e-05	0.000193	CbGpPWpGaD
Tyloxapol—LPL—Disease—EP300—hypertension	2.81e-05	0.000191	CbGpPWpGaD
Tyloxapol—LPL—Disease—SRC—hypertension	2.73e-05	0.000186	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SERPINE1—hypertension	2.71e-05	0.000184	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FGF2—hypertension	2.62e-05	0.000179	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—RHOA—hypertension	2.61e-05	0.000178	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3R1—hypertension	2.58e-05	0.000176	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NOS3—hypertension	2.58e-05	0.000176	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PTEN—hypertension	2.47e-05	0.000168	CbGpPWpGaD
Tyloxapol—LPL—Disease—MYC—hypertension	2.45e-05	0.000167	CbGpPWpGaD
Tyloxapol—LPL—Disease—TGFB1—hypertension	2.44e-05	0.000166	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—RELA—hypertension	2.43e-05	0.000166	CbGpPWpGaD
Tyloxapol—LPL—Disease—EGFR—hypertension	2.39e-05	0.000163	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MTOR—hypertension	2.39e-05	0.000163	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—EP300—hypertension	2.35e-05	0.00016	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CXCL8—hypertension	2.29e-05	0.000156	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MMP9—hypertension	2.07e-05	0.000141	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CDKN1A—hypertension	2.07e-05	0.000141	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PTEN—hypertension	2.06e-05	0.00014	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MAPK8—hypertension	2.02e-05	0.000137	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EP300—hypertension	1.97e-05	0.000134	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SRC—hypertension	1.91e-05	0.00013	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—VEGFA—hypertension	1.86e-05	0.000127	CbGpPWpGaD
Tyloxapol—LPL—Disease—IL6—hypertension	1.84e-05	0.000125	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MYC—hypertension	1.71e-05	0.000117	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TGFB1—hypertension	1.71e-05	0.000116	CbGpPWpGaD
Tyloxapol—LPL—Disease—AKT1—hypertension	1.7e-05	0.000116	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EGFR—hypertension	1.68e-05	0.000114	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—AKT1—hypertension	1.42e-05	9.68e-05	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TP53—hypertension	1.41e-05	9.59e-05	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IL6—hypertension	1.29e-05	8.78e-05	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AKT1—hypertension	1.19e-05	8.1e-05	CbGpPWpGaD
